Impact of Exenatide on Sleep in Type 2 Diabetes

Completed · Not applicable · Has a placebo group

Conditions studied: Type 2 Diabetes, Sleep Disordered Breathing

In brief

The investigators propose a pilot study to test the novel hypothesis that Exenatide treatment in patients with type 2 diabetes results in improved sleep duration and quality and to explore the relationship between improvements in sleep and measures of metabolic and circadian function. This project would be the first to probe the relationship between incretin hormone regulation, duration and intensity of sleep, glucose tolerance and circadian dysfunction in diabetic patients.

Key facts

Study ID
NCT01136798
Run by
University of Chicago
People needed
18
Starts
2010-06-01
Expected to finish
2016-09-01
Last updated by the study team
2018-09-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.